Skip to content

Crane Co. CR Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Flowserve logo
FlowserveFLS
Applied Industrial Technologies logo
Applied Industrial TechnologiesAIT
Curtiss-Wright logo
Curtiss-WrightCW
TransDigm Group logo
TransDigm GroupTDG
Howmet Aerospace logo
Howmet AerospaceHWM
RBC Bearings logo
RBC BearingsRBC

Other financials

Income statement

See full
Revenue$696.4M+24.9%
Gross profit$281.3M+18.4%
Operating income$100.1M-1.0%
Net income$67.1M-37.3%
EPS (diluted)$1.14-37.7%

Balance sheet

See full
Cash & equivalents$355.4M-18.3%
Total debt$1.2B+367%
Total equity$2.1B+19.4%
Total assets$4.1B+54.5%

Cash flow

See full
Operating cash flow-$29.5M+36.1%
CapEx$10.7M-24.6%
Free cash flow-$40.2M+33.4%

Valuation

See full
Market cap$12.41B+12.1%
Enterprise value$13.27B+24.4%
P/E38×+5.2×
P/S5.1×0.0×

Profitability

See full
Gross margin41.6%+0.3pp
Operating margin17.3%+0.1pp
Net margin13.4%-2.1pp
FCF margin14.8%+3.8pp

Returns & leverage

See full
Return on equity16.9%-4.4pp
Debt / equity0.6×+0.4×
Current ratio2.8×+0.8×

Where this comes from

Reported directly by Crane Co. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Crane Co.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Crane Co.'s common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Crane Co.'s common stock, shares authorized (in shares)?
Crane Co. (CR) reported common stock, shares authorized (in shares) of $66.48M in Q1 2026.
How has Crane Co.'s common stock, shares authorized (in shares) changed year-over-year?
Crane Co.'s common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $66.48M to $66.48M.
What is the long-term trend for Crane Co.'s common stock, shares authorized (in shares)?
Over 3 years (2022 to 2025), Crane Co.'s common stock, shares authorized (in shares) has grown at a -30.7% compound annual growth rate (CAGR), from $200M to $66.48M.